Literature DB >> 12446388

Rapid improvement of chronic interstitial keratitis with acitretin.

M Labetoulle1, H Offret, I Bournerias, E Frau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446388      PMCID: PMC1771387          DOI: 10.1136/bjo.86.12.1445-a

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

Review 1.  Acitretin in psoriasis: an overview of adverse effects.

Authors:  H I Katz; J Waalen; E E Leach
Journal:  J Am Acad Dermatol       Date:  1999-09       Impact factor: 11.527

2.  N-linked glycoside and glucuronide conjugates of the retinoid, acitretin, are biologically active in cornea and conjunctiva.

Authors:  J L Ubels; E M Woo; R W Curley
Journal:  J Ocul Pharmacol Ther       Date:  1998-12       Impact factor: 2.671

3.  Keratoconus as a possible side-effect of acitretin (neotigason) therapy.

Authors:  F Grønhøj Larsen; S R Andersen; K Weismann; K Julian; P Tfelt-Hansen
Journal:  Acta Derm Venereol       Date:  1993-04       Impact factor: 4.437

4.  [Chronic blepharoconjunctivitis during a treatment with acitretin (Soriatane)].

Authors:  P Denis; J P Nordmann; P Saiag; S Liotet; L Laroche; H Saraux
Journal:  J Fr Ophtalmol       Date:  1993       Impact factor: 0.818

5.  Retinoids increase urokinase-type plasminogen activator production by human retinal pigment epithelial cells in culture.

Authors:  I Immonen; V Sirén; R W Stephens; K Liesto; A Vaheri
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-05       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.